EMA approves Novo Nordisk plan to store insulin at room temperature for longer
Novo Nordisk has received a positive opinion from the European Medicines Agency to store two types of insulin outside of the fridge for up to four weeks, which Novo states will improve flexibility in a number of low and middle income countries.
by stefan nygaard hansen, translated by catherine brett
The European Medicines Agency (EMA) has approved an application from Novo Nordisk, allowing them to store Actrapid and Insulatard insulin doses outside of the refrigerator for up to four weeks. The insulin must still be stored at temperatures below 30 degrees Celsius.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk initiates phase I trial of oral device
For subscribers
Novo Nordisk target price increased by five institutions
For subscribers
